Brief: EyeGate Pharma Reports Q2 2021 Financial Results
12/08/2021 22:03
Aug 12 (Reuters) - EyeGate Pharmaceuticals Inc EYEG.O :
* EYEGATE PHARMA REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS AND
PROVIDES BUSINESS UPDATE
* EYEGATE PHARMACEUTICALS INC - CASH AND CASH EQUIVALENTS
WERE
$3.663 MILLION AS OF JUNE 30, 2021
Source text for Eikon: ID:nGNX7qZNbM
Further company coverage: EYEG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing